These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22674988)
1. Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme. Stahla-Beek HJ; April DG; Saeedi BJ; Hannah AM; Keenan SM; Geiss BJ J Virol; 2012 Aug; 86(16):8730-9. PubMed ID: 22674988 [TBL] [Abstract][Full Text] [Related]
2. A high-throughput screening assay for the identification of flavivirus NS5 capping enzyme GTP-binding inhibitors: implications for antiviral drug development. Geiss BJ; Stahla-Beek HJ; Hannah AM; Gari HH; Henderson BR; Saeedi BJ; Keenan SM J Biomol Screen; 2011 Sep; 16(8):852-61. PubMed ID: 21788392 [TBL] [Abstract][Full Text] [Related]
3. Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323. Bullard KM; Gullberg RC; Soltani E; Steel JJ; Geiss BJ; Keenan SM PLoS One; 2015; 10(6):e0130083. PubMed ID: 26075394 [TBL] [Abstract][Full Text] [Related]
4. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384 [TBL] [Abstract][Full Text] [Related]
12. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700 [TBL] [Abstract][Full Text] [Related]
13. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622 [TBL] [Abstract][Full Text] [Related]
14. Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme. Feibelman KM; Fuller BP; Li L; LaBarbera DV; Geiss BJ Antiviral Res; 2018 Jun; 154():124-131. PubMed ID: 29680670 [TBL] [Abstract][Full Text] [Related]
15. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Luo D; Vasudevan SG; Lescar J Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996 [TBL] [Abstract][Full Text] [Related]
16. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus. Lim SV; Rahman MB; Tejo BA BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153 [TBL] [Abstract][Full Text] [Related]
17. The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. Issur M; Geiss BJ; Bougie I; Picard-Jean F; Despins S; Mayette J; Hobdey SE; Bisaillon M RNA; 2009 Dec; 15(12):2340-50. PubMed ID: 19850911 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches. Kaushik S; Dar L; Kaushik S; Yadav JP J Ethnopharmacol; 2021 Mar; 267():113541. PubMed ID: 33152438 [TBL] [Abstract][Full Text] [Related]
19. Drug design for flavivirus proteases: what are we missing? Poulsen A; Kang C; Keller TH Curr Pharm Des; 2014; 20(21):3422-7. PubMed ID: 24001226 [TBL] [Abstract][Full Text] [Related]
20. Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain: implications for RNA-capping mechanisms in Flavivirus. Bollati M; Milani M; Mastrangelo E; Ricagno S; Tedeschi G; Nonnis S; Decroly E; Selisko B; de Lamballerie X; Coutard B; Canard B; Bolognesi M J Mol Biol; 2009 Jan; 385(1):140-52. PubMed ID: 18976670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]